Next-Gen CAR T & Novel SMA Drug Among New Entrants On EMA’s PRIME

Rare Pediatric Disease Drug & Multiple Myeloma Therapy Also Make The Grade

3D illustration of T cells attacking a cancer cell (CAR-T cell therapy) - Illustration
Autolus says its investigational treatment may overcome limitations of other CAR T-cell therapies • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from R&D

More from Pink Sheet